Microorganisms (Jan 2021)

Intake of <i>Lactobacillus delbrueckii</i> (pExu:<i>hsp65</i>) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis

  • Fernanda Alvarenga Lima Barroso,
  • Luís Cláudio Lima de Jesus,
  • Camila Prosperi de Castro,
  • Viviane Lima Batista,
  • Ênio Ferreira,
  • Renata Salgado Fernandes,
  • André Luís Branco de Barros,
  • Sophie Yvette Leclerq,
  • Vasco Azevedo,
  • Pamela Mancha-Agresti,
  • Mariana Martins Drumond

DOI
https://doi.org/10.3390/microorganisms9010107
Journal volume & issue
Vol. 9, no. 1
p. 107

Abstract

Read online

5-Fluorouracil (5-FU) is an antineoplastic drug that causes, as a side effect, intestinal mucositis, acute inflammation in the small bowel. The Heat Shock Protein (Hsp) are highly expressed in inflammatory conditions, developing an important role in immune modulation. Thus, they are potential candidates for the treatment of inflammatory diseases. In the mucositis mouse model, the present study aimed to evaluate the beneficial effect of oral administration of milk fermented by Lactobacillus delbrueckii CIDCA 133 (pExu:hsp65), a recombinant strain. This approach showed increased levels of sIgA in the intestinal fluid, reducing inflammatory infiltrate and intestinal permeability. Additionally, the histological score was improved. Protection was associated with a reduction in the gene expression of pro-inflammatory cytokines such as Tnf, Il6, Il12, and Il1b, and an increase in Il10, Muc2, and claudin 1 (Cldn1) and 2 (Cldn2) gene expression in ileum tissue. These findings are corroborated with the increased number of goblet cells, the electronic microscopy images, and the reduction of intestinal permeability. The administration of milk fermented by this recombinant probiotic strain was also able to reverse the high levels of gene expression of Tlrs caused by the 5-FU. Thus, the rCIDCA 133:Hsp65 strain was revealed to be a promising preventive strategy for small bowel inflammation.

Keywords